Every 8-K that Lite Strategy, Inc. (LITS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow LITS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LITS filings page.
Lite Strategy, Inc. repurchased approximately 4.9 million shares of common stock between December 2025 and July 17, 2026 under its Share Repurchase Program, equal to 13% of the shares outstanding when the program began. The company deployed about $5.4 million at an average price of $1.11 per share, funded entirely through active treasury operations rather than borrowing.
The company sold a measured portion of its Litecoin (LTC) treasury asset and used covered call premiums to buy back stock when it traded at a substantial discount to the net asset value (NAV) of its Litecoin holdings. During the repurchase period, the discount to NAV reached the low 40% range and, according to the company, narrowed to below 25% as repurchases progressed. As of July 17, 2026, Lite Strategy holds 819,070 LTC against 31,882,648 shares outstanding and reports carrying no debt.
Preliminary, unaudited figures indicate fiscal year 2026 ended with cash of $5.7 million and total liabilities of $1.1 million, which the company notes may change once financial closing and the independent audit are complete. Lite Strategy plans to continue the repurchase program while it views it as value accretive and intends to fund additional buybacks through its active Litecoin treasury management.
Lite Strategy, Inc., a Nasdaq-listed company, presents itself as a public equity vehicle focused on Litecoin, aiming to institutionalize LTC as a strategic treasury asset. It emphasizes being the only Nasdaq-listed public company with Litecoin as its primary treasury reserve asset.
The company reports holding 830,378 LTC as of July 2, 2026, roughly 1.1% of total LTC supply, and running a covered call options program that has generated $0.7 million in premiums since October 2025. Capital allocation tools include a share repurchase program of up to $25 million designed to narrow the discount to NAV and a $1 million lead SAFE investment in LitVM at a $50 million post-money valuation cap, with a token warrant for up to 2% of LitVM’s token supply. Additional optionality comes from a pharmaceutical asset portfolio, including potential future payments of up to $62 million tied to ME-344 milestones.
Lite Strategy, Inc. reported fiscal 2026 third quarter results, emphasizing its strategy of using Litecoin (LTC) as its primary treasury reserve asset and returning capital to shareholders. The company highlighted its active covered call options program, which has generated $0.7 million in net proceeds since October 2025.
Lite Strategy deployed covered call proceeds and 35,250 LTC to repurchase 1,629,136 shares under a broader $25 million share repurchase authorization, reflecting a focus on capital discipline and net asset value per share. Management also noted ongoing pre-clinical pharmaceutical programs as potential sources of non-dilutive capital.
The company framed recent Securities and Exchange Commission guidance indicating Litecoin exhibits digital commodity characteristics as a meaningful step toward regulatory clarity. Looking ahead, Lite Strategy plans to scale its options program, continue repurchases, and pursue strategic investments and partnerships that support broader Litecoin ecosystem growth.
Lite Strategy, Inc. reported fiscal 2026 second quarter results centered on a new, more active use of its Litecoin treasury and capital return strategy. The company began transforming its LTC holdings into a “productive reserve asset” by launching a covered call options program that generated nearly $600,000 in gross premiums in the quarter.
Management also used proceeds from these treasury operations to commence a $25 million stock repurchase program, aiming to practice disciplined capital allocation and address the discount to net asset value. As of December 31, 2025, Lite Strategy held $8.8 million in cash and cash equivalents and initiated pre-clinical R&D work on its drug candidate pipeline for potential out-licensing or sale opportunities.
Lite Strategy, Inc. reported results of its fiscal 2026 Annual Meeting held on February 12, 2026. Stockholders approved the 2026 Omnibus Equity Compensation Plan, which became effective upon approval and supports the company’s future stock-based incentive awards.
Approval of the 2026 plan also satisfied the contingency for previously disclosed Replacement Options granted to Mr. Justin J. File to purchase 455,000 shares of common stock. Stockholders elected Mr. File and Mr. Joshua Riezman as directors to terms running through fiscal 2029, approved an advisory vote on executive compensation, and ratified CBIZ CPAs as independent auditors for the fiscal year ending June 30, 2026.
At the meeting, 19,437,130 shares of common stock were represented by proxy out of 36,785,397 shares outstanding and entitled to vote, indicating substantial shareholder participation.
Lite Strategy, Inc. filed an amended report to correct the previously disclosed size of stock options granted to its Chief Executive Officer, Justin J. File. The original filing stated that Mr. File received options to purchase 635,000 shares of common stock, but the actual grant on November 14, 2025 was for options on 180,000 shares under the company’s existing equity plan.
To address this discrepancy, on November 20, 2025 the board approved additional “Replacement Options” for Mr. File to purchase 455,000 shares of common stock. These replacement options carry an exercise price of $2.02 per share and follow the same vesting terms as the original 180,000-share grant. The replacement options will only be issued if stockholders approve a new omnibus equity plan at the company’s 2026 annual meeting; they will be cancelled if that plan is not approved.
Lite Strategy, Inc. announced that its Board has appointed Justin J. File as permanent Chief Executive Officer and elected him to the Board of Directors, effective immediately. He will continue to serve as Chief Financial Officer and Secretary, consolidating the company’s top executive and financial roles under a single leader.
In connection with his promotion, Mr. File received stock options to purchase 635,000 shares of common stock at an exercise price of $2.02 per share, which was the closing price on the grant date. These options were issued under the company’s Amended and Restated 2008 Stock Omnibus Equity Compensation Plan and vest in 36 monthly installments starting December 14, 2025, with a 10-year term. Mr. File will not receive additional compensation for serving on the Board, and the company plans to enter into an addendum to his employment agreement to document the new terms.
Lite Strategy, Inc. (LITS) filed an 8-K announcing two items. First, Thomas C. Reynolds, M.D., Ph.D. notified the Board on October 24, 2025 of his decision to resign as a director, effective November 4, 2025. He will also step down from the Compensation Committee and the Nominating & Governance Committee. The company stated his resignation is not the result of any disagreement with operations, policies, or practices.
Second, the Board authorized a common stock repurchase program under which the company may purchase up to $25 million of its common stock, as announced via press release on October 29, 2025. Repurchases may occur in the open market, through privately negotiated transactions, or under Rule 10b5-1 plans, subject to market conditions, applicable law, and other factors. The program does not obligate any repurchases and may be suspended or discontinued at any time.
Lite Strategy, Inc. reported that an investor exercised a portion of previously issued pre-funded warrants. These warrants were originally issued on July 22, 2025 in a private PIPE offering at an offering price of $3.4199 per pre-funded warrant for up to 6,022,869 shares of common stock.
On September 10, 2025, the investor exercised 1,595,000 pre-funded warrants in a cashless transaction, receiving 1,594,944 shares of Lite Strategy common stock. The warrants and the shares issued upon exercise were issued in transactions relying on private offering exemptions under Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D.